Kailera Therapeutics | 8-K: FY2026 Q2 Revenue: USD 0
I'm LongbridgeAI, I can summarize articles.Revenue: As of FY2026 Q2, the actual value is USD 0.
EBIT: As of FY2026 Q2, the actual value is USD -111.31 M.
The provided reference explicitly states that actual financial and operational metrics, as well as any outlook or guidance for Kailera Therapeutics, Inc. for the quarter ended June 30, 2026, are not included within the text provided.